Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner
Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner
Read moreMon, 23rd Aug 2021 15:12
Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner
Read moreOncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses
Read moreOncimmune Reports Study Results For Cancer Test Product
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreOncimmune And Biodesix Complete US Agreement For Lung Cancer Test
Read moreOncimmune Annual Loss Deepens On Costs But Makes Operational Progress
Read moreCORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility
Read moreOncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks
Read more(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has secured a credit facility of €8.5m (£7.5m) with IPF Management, it announced on Friday.
Read more(Alliance News) - Oncimmune Holdings PLC on Friday said it has secured a credit facility of EUR8.5 million with IPF Management SA.The immunodiagnostics company said it will immediately draw
Read more(Alliance News) - Oncimmune Holdings PLC on Monday announced positive results from a trial of its EarlyCDT Lung test to detect early stage lung cancer.Shares in Oncimmune were up 5.5% at in
Read more(Alliance News) - Oncimmune Holdings PLC on Monday said Sabartech SL, its existing distributor in Spain and Portugal, has agreed with Vithas Group to sell EarlyCDT Lung as a screening test for of
Read more(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has entered into an exclusive partnership agreement, it announced on Friday, which it said could "unlock the full potential" of its 'EarlyCDT Lung' product in the United States.
Read more(Sharecast News) - Immunodiagnostics firm Oncimmune told investors on Wednesday it was confident it could generate "material profitable revenues" on the back of several business developments.
Read moreLONDON (Alliance News) - Oncimmune Holdings PLC on Tuesday reported positive top line results from its early cancer detection test in patients with lung cancer.Oncimmune Holdings shares at
Read more